On August 9, 2019, Kainos Medicine, Inc. (XKON:A220250) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,580 KRW | -6.82% | +30.48% | +6.02% |
2023 | Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index | CI |
2022 | Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
+6.02% | 93.38M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+47.36% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- A284620 Stock
- News Kainos Medicine, Inc.
- Kainos Medicine, Inc. announced that it has received KRW 3.9999933 billion in funding from NH Investment & Securities Co., Ltd., and another investor